CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy

Saved in:
Bibliographic Details
Published in:Kidney international reports 2017-01, Vol.2 (1), p.89-90
Main Authors: Ramachandran, Raja, Yadav, Ashok K, Kumar, Vinod, Gupta, Krishan L, Kohli, Harbir S
Format: Article
Language:English
Subjects:
Research Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2468-0249
2468-0249
DOI:10.1016/j.ekir.2016.08.019